Senior Executive Officers

Ray L. Parvin, Chairman and CEO

Ray L. Parvin is a graduate of the University of Southern California with a master’s degree in biochemistry. Ray began his career in the clinical department of GlaxoSmithKline, where he held the position of regional manager for clinical research in the field of oncology. Subsequently, Ray worked as the regional director of the department for work with health authorities of the commercial department.

Ray became the head of our company in 2012.

Stephen J. Erdmann, Chief Scientific Officer

Prior to joining our team, Stephen was Director of Corporate Development at Acino Pharma, where he was responsible for acquiring new assets and expanding the company’s portfolio. Previously, Stephen worked for Raifarm, a leading healthcare consulting company in emerging markets. Stephen also worked in the investment banking department of Credit Suisse and in the department of management consulting at Deloitte Consulting. Stephen graduated from Tufts University, Massachusetts, as well as from the Stern School of Business at New York University, where he received an MBA. Stephen has over 30 years of research experience in the area of stem cells and regenerative medicine. He is currently an Adjunct Professor at the Institute for Regenerative Medicine in St. Louis, MO.

Aurea M. Rankin, Vice President of Regulartory

Aurea received a higher medical education at the Institute for Regenerative Medicine, worked as a researcher and assistant at the Department of Immunology. Aurea began her career in clinical research at GlaxoWellcome, then worked at the American contract research organization ClinStar, where she held the position of project manager, managing international phase Ib-IV clinical trials in the USA. Aurea participates in the creation of a professional team, training of employees, participates in the formation and development of new services of the company, organization and implementation of clinical projects of all phases and in various therapeutic areas. As Vice President of Regulartory, Aurea coordinates the work of project managers, ensuring successful research in clinical centers in the USA and Europe.

Jose M. Hanson, Senior Director of Manufacturing

Jose began his career in the clinical department of GlaxoSmithKline. After that, he moved to Novartis as a Senior Clinical Research Specialist, and also acted as a local project manager and a leading clinical research specialist in international projects. Jose led the Cystic Fibrosis Research Group and provided functional leadership to 10 clinical research specialists. Jose has extensive experience in conducting phase I-IV research in various therapeutic areas (such as oncology, cardiology, pulmonology, neurology, etc.).

Alberta J. Miller, Director of Operations

Alberta graduated with a degree in international business and a master’s degree in economics. Alberta joined our team as a Business Development Manager in 2015, soon her functionality was supplemented with marketing activities. She plays a key role in the design and implementation of business development and marketing strategies, increasing the number of implemented projects and services offered. Alberta has run a number of online and offline promotions. Prior to joining our team, Alberta worked in the French pharmaceutical group of companies – INNOTHERA, where she was responsible for monthly reporting of business development and marketing activities to the Board of Directors, as well as developed a procurement system and organized many international and local marketing events and cycle meetings.